EFFICACY AND SAFETY OF FILCOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS NAiVE TO METHOTREXATE. THERAPY: FINCH 3 PRIMARY OUTCOME RESULTS

被引:0
|
作者
Valenzuela, G. [1 ]
van der Heijde, D. [2 ]
Westhovens, R. [3 ]
Rigby, W. [4 ]
Ching, D. [5 ]
Bartok, B. [6 ]
Matzkies, F. [6 ]
Yin, Z. [6 ]
Guo, Y. [6 ]
Tasset, C. [7 ]
Sundy, J. [6 ]
Mozaffarian, N. [6 ]
Messina, O. [8 ,9 ]
Landewe, R. [10 ]
Atsumi, T. [11 ]
Burmester, G. [12 ]
机构
[1] Integral Rheumatol & Immunol Specialists, Plantation, FL USA
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Univ Hosp, Cleveland, OH USA
[4] Dartmouth Coll, Hanover, NH 03755 USA
[5] Timaru Hosp, Timaru, New Zealand
[6] Gilead Sci, Foster City, CA USA
[7] Galapagos NV, Mechelen, Belgium
[8] Cosme Argerich Hosp, Buenos Aires, DF, Argentina
[9] IRO Med Ctr, Azzano San Paolo, Italy
[10] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[11] Hokkaido Univ, Sapporo, Hokkaido, Japan
[12] Charite, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
297
引用
收藏
页码:128 / 128
页数:1
相关论文
共 50 条
  • [31] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized, Placebo-Controlled Trial Of Golimumab In Methotrexate-naive Patients With Rheumatoid Arthritis
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin A.
    Park, Won
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S188 - S189
  • [32] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Emery, Paul
    Fleischmann, Roy M.
    Strusberg, Ingrid
    Durez, Patrick
    Nash, Peter
    Amante, Eric
    Churchill, Melvin
    Park, W.
    Pons-Estel, Bernardo
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 93 - 93
  • [33] Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
    Fleischmann, Roy M.
    Huizinga, Tom W. J.
    Kavanaugh, Arthur F.
    Wilkinson, Bethanie
    Kwok, Kenneth
    DeMasi, Ryan
    van Vollenhoven, Ronald F.
    RMD OPEN, 2016, 2 (02):
  • [34] Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register
    Sebastiani, Marco
    Anelli, Maria Grazia
    Atzeni, Fabiola
    Bazzani, Chiara
    Farina, Ilaria
    Fedele, Anna Laura
    Favalli, Ennio Giulio
    Fineschi, Irene
    Cino, Nicolo
    Dal Forno, Ilaria
    Gasparini, Stefania
    Cassara, Emanuele
    Giardina, Rita
    Bruschi, Eleonora
    Addimanda, Olga
    Cassone, Giulia
    Lopriore, Simona
    Sarzi-Puttini, Piercarlo
    Filippini, Matteo
    Pignatti, Federica
    Gremese, Elisa
    Biggioggero, Martina
    Manganelli, Stefania
    Amato, Giorgio
    Caimmi, Cristian
    Salaffi, Fausto
    Iannone, Florenzo
    Ferri, Clodoveo
    Sandri, Gilda
    Lapadula, Giovanni
    Gorla, Roberto
    Govoni, Marcello
    Ferraccioli, Gianfranco
    Marchesoni, Antonio
    Galeazzi, Mauro
    Foti, Rosario
    Carletto, Antonio
    Cantini, Fabrizio
    Triolo, Giovanni
    Epis, Oscar Massimiliano
    Salvarani, Carlo
    JOINT BONE SPINE, 2014, 81 (06) : 508 - 512
  • [35] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: 52-Week Results
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon-Campos, J-Abraham
    Baraf, Herbert S.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Mozaffarian, Neelufar
    Landewe, Robert
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [36] EFFICACY AND SAFETY OF SARILUMAB PLUS METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS AND IN THOSE WHO ARE BIOLOGIC-NAIVE
    Fleischmann, Roy
    Genovese, Mark
    Fan, Chunpeng
    Fiore, Stefano
    Decktor, Dennis
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 122 - 122
  • [37] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS
    Rischmueller, Maureen
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
  • [38] Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] Filgotinib Provided Rapid and Sustained Improvements of Work Productivity and Activity in Patients With Rheumatoid Arthritis who are Methotrexate-naive: Results from the FINCH-3 Study
    Pope, Janet
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lee, Susan
    Hasegawa, Ken
    Hendrikx, Thijs
    Boonen, Annelies
    Combe, Bernard
    Walker, David
    Alten, Rieke
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1172 - 1173
  • [40] Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine
    Clegg, DO
    Dietz, F
    Duffy, J
    Willkens, RF
    Hurd, E
    Germain, BF
    Wall, B
    Wallace, DJ
    Bell, CL
    Sleckman, J
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (10) : 1896 - 1902